Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia - The pathogenic role of IgG

By Untch B.   Ahmad S.   Jeske W.P.   Messmore H.L.   Hoppensteadt D.A.   Walenga J.M.   Lietz H.   Fareed J.  

Thrombosis Research, Vol. 105, Iss. 2, 2002-01 ,pp. : 117-123

Elsevier

Access to resources Recommend Favorite

Treatment of Patients with a History of Heparin-Induced Thrombocytopenia and Anti-Lepirudin Antibodies with Argatroban

By Job Harenberg   Ingrid Jörg   Tivadar Fenyvesi   Lukas Piazolo  

Journal of Thrombosis and Thrombolysis, Vol. 19, Iss. 1, 2005-02 ,pp. : 65-69

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Patients with a History of Heparin-Induced Thrombocytopenia and Anti-Lepirudin Antibodies with Argatroban

By Job Harenberg   Ingrid Jörg   Tivadar Fenyvesi   Lukas Piazolo  

Journal of Thrombosis and Thrombolysis, Vol. 20, Iss. 2, 2005-10 ,pp. : 137-137

Springer Publishing Company

Access to resources Recommend Favorite

Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodies

By Untch B.   Ahmad S.   Messmore H.L.   Schultz C.L.   Ma Q.   Hoppensteadt D.A.   Walenga J.M.   Fareed J.  

Thrombosis Research, Vol. 106, Iss. 2, 2002-04 ,pp. : 149-156

Elsevier

Access to resources Recommend Favorite

Argatroban therapy does not generate antibodies that alter its anticoagulant activity in patients with heparin-induced thrombocytopenia

By Walenga J.M.   Ahmad S.   Hoppensteadt D.   Iqbal O.   Hursting M.J.   Lewis B.E.  

Thrombosis Research, Vol. 105, Iss. 5, 2002-03 ,pp. : 401-405

Elsevier

Access to resources Recommend Favorite